Xspray Pharma appoints Blake Leitch as CEO, Per Andersson to become CSO
Xspray Pharma has appointed Blake Leitch as CEO, with the start date no later than June 1, 2026. Current CEO Per Andersson will become CSO.
Xspray Pharma has appointed Blake Leitch as CEO, with the start date no later than June 1, 2026. Current CEO Per Andersson will become CSO.
Fresenius extends CEO Michael Sen’s contract early, taking it through 2031. Helios executive Christian Pawlu will join the Management Board on July 1, 2026.
Roche names Mark Dawson as Head of Pharma Research and Early Development from 1 May 2026 and adds him to the Enlarged Corporate Executive Committee.
Julia Huhn has led Communication & Public Affairs at L’Oréal DACH since 15 February. She succeeds Stefan Geister and joins from Santander.
Linda Maria Diodati became Managing Director of Thieme Media on 1 February 2026. She succeeds Oliver Fock, who moved into a staff role.
Biogen will shift its board leadership: Dr. Maria C. Freire is set to become chair after the June 9, 2026 annual meeting.
Sanofi has appointed Belén Garijo as CEO. Paul Hudson will leave on Feb. 17, 2026, with Olivier Charmeil serving as interim leader.
Engelhard has created a Transformation Office and appointed Ann-Katrin Frank as Chief Commercial Strategy Officer to steer strategic development.
Daiichi Sankyo has appointed Dr. Veronika Rozehnal as the new Head of the Translational Research Center Europe. She succeeds Dr. Jürgen Müller, who is retiring after nearly 30 years of research service.
After 22 years at Novo Nordisk, Thomas Rantzau steps down from the Board of Directors. His former alternate, Tanja Villumsen, assumes the role of employee representative with immediate effect.
Merck has appointed Benjamin Hein as a member of the Executive Board and CEO Electronics. The experienced executive will assume the role on May 1, 2026, succeeding Kai Beckmann.
As of January 1, 2026, Jonas Gehrling has joined the management team of Serviceplan Content Health. Together with Nadine van Maanen, he will lead the Berlin-based healthcare content agency.
Psyma+Exevia Health GmbH sets the course for the future: Heidi Lüttgens assumes management responsibility from Roland Herterich and Norbert Schell. The leadership transition combines continuity with new momentum for growth and innovation.
As of February 1, 2026, Alliance Healthcare Germany will bundle Sales and Marketing under one leadership. Florian Truckenbrodt will be responsible for both areas to further strengthen pharmacies in the market.
FUNKE strengthens its digital transformation and welcomes back Carsten Groß as Managing Director Digital Publishing. Starting February 2026, he will assume strategic responsibility for all digital growth areas within the regional media division.
Fresenius is restructuring its global communications: Katrin Kerner and Christian Wagner are taking over the Corporate Communications function on an interim basis. Both report directly to CEO Michael Sen.
Vetter announces the retirement of long-serving Managing Director Thomas Otto and presents a strategically planned succession model. He will remain with the company in an advisory capacity.
The Insurance Chamber is accelerating its marketing transformation and creating two new key roles for data-driven and digital growth. Annika Bäcker and Stefan Weller take on central leadership positions.
Scholz & Friends appoints Andreas Bilgeri as Managing Director of its Hamburg office. Starting December 1, 2025, he will take on strategic responsibility for key client mandates.
The Federal Assembly of the German Red Cross (GRC) has unanimously elected Hermann Gröhe as its new President. He succeeds Gerda Hasselfeldt and brings extensive experience from politics and the health sector.